| 000 | 01803 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513211147.0 | ||
| 264 | 0 | _c20000907 | |
| 008 | 200009s 0 0 eng d | ||
| 022 | _a0168-8227 | ||
| 024 | 7 |
_a10.1016/s0168-8227(00)00139-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchiel, R | |
| 245 | 0 | 0 |
_aGAD autoantibodies in a selection-free population of insulin-treated diabetic patients: indicator of a high prevalence of LADA? _h[electronic resource] |
| 260 |
_bDiabetes research and clinical practice _cJul 2000 |
||
| 300 |
_a33-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntibodies, Monoclonal |
| 650 | 0 | 4 |
_aAutoantibodies _xblood |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Neuropathies _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Retinopathy _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGermany _xepidemiology |
| 650 | 0 | 4 |
_aGlutamate Decarboxylase _ximmunology |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xanalysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Diseases _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNervous System Diseases _xcomplications |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aRadioimmunoassay |
| 650 | 0 | 4 |
_aRetinal Diseases _xcomplications |
| 650 | 0 | 4 | _aSeroepidemiologic Studies |
| 700 | 1 | _aMüller, U A | |
| 773 | 0 |
_tDiabetes research and clinical practice _gvol. 49 _gno. 1 _gp. 33-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0168-8227(00)00139-x _zAvailable from publisher's website |
| 999 |
_c10759927 _d10759927 |
||